A Multicenter, Double‐Blind, Phase 3 Study of the Efficacy and Safety of Anifrolumab in Myositis: Rationale and Design of the JASMINE Trial

Rohit Aggarwal, Hector Chinoy, Ingrid E. Lundberg, Masataka Kuwana, Ruth Ann Vleugels, Consuelo Anzilotti, Andrew Beaton, Celeste Cummings, Tina Luu, Maroua Benghoul
ACR Open Rheumatology · Wiley · 2026-11-19 · DOI: 10.1002/acr2.90155

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles